MET and hepatocellular carcinoma: The combination of HGF and c-Met leads to the phosphorylation of downstream effectors, such as PI3K/Akt, RAS/MAPK, nonreceptor tyrosine kinase, and Focal adhesion kinase, which promotes the survival, proliferation, invasion, and metastasis of HCC (Han et al., 2019).